Womack Financial’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.15M Sell
2,175
-185
-8% -$85.4K 0.76% 32
2026
Q1
$1.13M Sell
2,360
-25
-1% -$12.8K 0.83% 31
2025
Q4
$1.34M Sell
2,385
-145
-6% -$82.3K 0.99% 31
2025
Q3
$1.3M Sell
2,530
-60
-2% -$26.2K 0.99% 30
2025
Q2
$813K Sell
2,590
-10
-0.4% -$3K 0.68% 34
2025
Q1
$792K Sell
2,600
-25
-1% -$8.41K 0.73% 30
2024
Q4
$872K Buy
+2,625
New +$890K 0.77% 30

Other funds holding MEDP

Womack Financial's MEDP Position: Q2 2026 in Review

Womack Financial reduced its Medpace (MEDP) stake by 7.8% in Q2 2026, selling an estimated $85.4K and leaving 2,175 shares worth $1.15M. The position accounts for 0.76% of the portfolio, ranked #32.

Womack Financial first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.34M in Q4 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Womack Financial held 2,175 shares of Medpace worth $1.15M as of Q2 2026.
  • Womack Financial sold 185 Medpace shares in Q2 2026, an estimated $85.4K.
  • Medpace made up 0.76% of Womack Financial's portfolio in Q2 2026, its #32 holding.
  • Womack Financial first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Womack Financial's Medpace position peaked at $1.34M in Q4 2025.
  • 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Womack Financial's 13F filing for Q2 2026, filed 14 Aug 2026.